Logo image of AMTM

AMENTUM HOLDINGS INC (AMTM) Stock Fundamental Analysis

NYSE:AMTM - New York Stock Exchange, Inc. - US0239391016 - Common Stock - Currency: USD

26.53  +0.88 (+3.43%)

After market: 26.8 +0.27 (+1.02%)

Fundamental Rating

3

Taking everything into account, AMTM scores 3 out of 10 in our fundamental rating. AMTM was compared to 80 industry peers in the Professional Services industry. Both the profitability and financial health of AMTM have multiple concerns. AMTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year AMTM was profitable.
AMTM had a positive operating cash flow in the past year.
AMTM Yearly Net Income VS EBIT VS OCF VS FCFAMTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

AMTM has a Return On Assets of 0.44%. This is in the lower half of the industry: AMTM underperforms 60.00% of its industry peers.
The Return On Equity of AMTM (1.17%) is worse than 60.00% of its industry peers.
AMTM has a worse Return On Invested Capital (2.48%) than 61.25% of its industry peers.
AMTM had an Average Return On Invested Capital over the past 3 years of 2.31%. This is significantly below the industry average of 12.73%.
The last Return On Invested Capital (2.48%) for AMTM is above the 3 year average (2.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.44%
ROE 1.17%
ROIC 2.48%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
AMTM Yearly ROA, ROE, ROICAMTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

AMTM has a Profit Margin of 0.41%. This is comparable to the rest of the industry: AMTM outperforms 41.25% of its industry peers.
AMTM has a Operating Margin of 2.39%. This is in the lower half of the industry: AMTM underperforms 60.00% of its industry peers.
AMTM's Operating Margin has been stable in the last couple of years.
The Gross Margin of AMTM (10.21%) is worse than 87.50% of its industry peers.
AMTM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.39%
PM (TTM) 0.41%
GM 10.21%
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
AMTM Yearly Profit, Operating, Gross MarginsAMTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

More info and screens

2

2. Health

2.1 Basic Checks

AMTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AMTM has been increased compared to 1 year ago.
The debt/assets ratio for AMTM has been reduced compared to a year ago.
AMTM Yearly Shares OutstandingAMTM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M
AMTM Yearly Total Debt VS Total AssetsAMTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that AMTM is in the distress zone and has some risk of bankruptcy.
AMTM's Altman-Z score of 1.74 is on the low side compared to the rest of the industry. AMTM is outperformed by 71.25% of its industry peers.
The Debt to FCF ratio of AMTM is 32.53, which is on the high side as it means it would take AMTM, 32.53 years of fcf income to pay off all of its debts.
AMTM's Debt to FCF ratio of 32.53 is on the low side compared to the rest of the industry. AMTM is outperformed by 67.50% of its industry peers.
AMTM has a Debt/Equity ratio of 1.00. This is a neutral value indicating AMTM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 1.00, AMTM is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 32.53
Altman-Z 1.74
ROIC/WACC0.28
WACC8.94%
AMTM Yearly LT Debt VS Equity VS FCFAMTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

AMTM has a Current Ratio of 1.58. This is a normal value and indicates that AMTM is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.58, AMTM perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
A Quick Ratio of 1.58 indicates that AMTM should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.58, AMTM perfoms like the industry average, outperforming 57.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
AMTM Yearly Current Assets VS Current LiabilitesAMTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1B 2B 3B

More info and screens

5

3. Growth

3.1 Past

AMTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.53%, which is quite impressive.
AMTM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.65%.
The Revenue has been growing by 12.53% on average over the past years. This is quite good.
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%124.64%
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%66.25%

3.2 Future

Based on estimates for the next years, AMTM will show a very strong growth in Earnings Per Share. The EPS will grow by 72.01% on average per year.
Based on estimates for the next years, AMTM will show a small growth in Revenue. The Revenue will grow by 2.54% on average per year.
EPS Next Y312.14%
EPS Next 2Y113.56%
EPS Next 3Y72.01%
EPS Next 5YN/A
Revenue Next Year2.32%
Revenue Next 2Y2.29%
Revenue Next 3Y2.54%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMTM Yearly Revenue VS EstimatesAMTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
AMTM Yearly EPS VS EstimatesAMTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.82 indicates a correct valuation of AMTM.
AMTM's Price/Earnings ratio is rather cheap when compared to the industry. AMTM is cheaper than 82.50% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.11. AMTM is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 10.97 indicates a reasonable valuation of AMTM.
80.00% of the companies in the same industry are more expensive than AMTM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.78, AMTM is valued rather cheaply.
Industry RankSector Rank
PE 12.82
Fwd PE 10.97
AMTM Price Earnings VS Forward Price EarningsAMTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

62.50% of the companies in the same industry are more expensive than AMTM, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AMTM is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 46.84
EV/EBITDA 13.28
AMTM Per share dataAMTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AMTM's earnings are expected to grow with 72.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y113.56%
EPS Next 3Y72.01%

More info and screens

0

5. Dividend

5.1 Amount

AMTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMENTUM HOLDINGS INC

NYSE:AMTM (8/13/2025, 8:04:00 PM)

After market: 26.8 +0.27 (+1.02%)

26.53

+0.88 (+3.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)N/A N/A
Inst Owners62.75%
Inst Owner Change0.5%
Ins Owners0.56%
Ins Owner Change10.42%
Market Cap6.46B
Analysts74.67
Price Target26.63 (0.38%)
Short Float %5.99%
Short Ratio4.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.54%
Min EPS beat(2)2.91%
Max EPS beat(2)10.16%
EPS beat(4)4
Avg EPS beat(4)26.92%
Min EPS beat(4)2.91%
Max EPS beat(4)84.31%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)-0.23%
Revenue beat(4)2
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)2.38%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.98%
PT rev (3m)7.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.03%
EPS NY rev (1m)0%
EPS NY rev (3m)1.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.15%
Valuation
Industry RankSector Rank
PE 12.82
Fwd PE 10.97
P/S 0.51
P/FCF 46.84
P/OCF 40.34
P/B 1.45
P/tB N/A
EV/EBITDA 13.28
EPS(TTM)2.07
EY7.8%
EPS(NY)2.42
Fwd EY9.12%
FCF(TTM)0.57
FCFY2.14%
OCF(TTM)0.66
OCFY2.48%
SpS52.11
BVpS18.32
TBVpS-13.29
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.17%
ROCE 3.14%
ROIC 2.48%
ROICexc 2.69%
ROICexgc 19.81%
OM 2.39%
PM (TTM) 0.41%
GM 10.21%
FCFM 1.09%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
ROICexc(3y)2.45%
ROICexc(5y)N/A
ROICexgc(3y)14.93%
ROICexgc(5y)N/A
ROCE(3y)2.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 32.53
Debt/EBITDA 5.91
Cap/Depr 4.94%
Cap/Sales 0.17%
Interest Coverage 250
Cash Conversion 21.28%
Profit Quality 264.03%
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 1.74
F-Score6
WACC8.94%
ROIC/WACC0.28
Cap/Depr(3y)5.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%124.64%
EPS Next Y312.14%
EPS Next 2Y113.56%
EPS Next 3Y72.01%
EPS Next 5YN/A
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%66.25%
Revenue Next Year2.32%
Revenue Next 2Y2.29%
Revenue Next 3Y2.54%
Revenue Next 5YN/A
EBIT growth 1Y16.17%
EBIT growth 3Y11.69%
EBIT growth 5YN/A
EBIT Next Year106.14%
EBIT Next 3Y31.79%
EBIT Next 5YN/A
FCF growth 1Y-30.5%
FCF growth 3Y-45.82%
FCF growth 5YN/A
OCF growth 1Y-30.26%
OCF growth 3Y-42.49%
OCF growth 5YN/A